We are a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system
Total raised: $10.392228M
Founded date: 1999
Investors 2
| Date | Name | Website |
| - | Omega Fund... | omegafunds... |
| - | TVM Capita... | tvm-lifesc... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 20.11.2015 | - | $5.4M | - | venturebea... |
| 15.02.2011 | - | $4.992228M | - | tvm-lifesc... |
Mentions in press and media 38
| Date | Title | Description | Category | Author | Source |
| 18.10.2021 | Newron Pha... | DGAP-News: Newron Pharmaceutic... | - | - | marketscre... |
| 16.09.2021 | Newron ann... | EQS Group-Ad-hoc: Newron Pharm... | - | - | marketscre... |
| 16.09.2021 | PRESS RELE... | DGAP-News: Newron Pharmaceutic... | - | - | marketscre... |
| 16.09.2021 | Newron Pha... | DGAP-News: Newron Pharmaceutic... | - | - | marketscre... |
| 06.09.2021 | Newron Pha... | DGAP-News: Newron Pharmaceutic... | - | - | marketscre... |
| 06.09.2021 | Newron Pha... | DGAP-News: Newron Pharmaceutic... | - | - | marketscre... |
| 20.05.2021 | NEWRON PHA... | DGAP-News: Newron Pharmaceutic... | - | - | marketscre... |
| 04.05.2021 | NEWRON PHA... | EQS Group-Ad-hoc: Newron Pharm... | - | - | marketscre... |
| 04.05.2021 | NEWRON PHA... | DGAP-News: Newron Pharmaceutic... | - | - | marketscre... |
| 13.04.2021 | NEWRON PHA... | DGAP-News: Newron Pharmaceutic... | - | - | marketscre... |
Show more